Among the 112 HR+ MBCs classified as HER2-negative, 73 cases (65.2%) fell under the HER2-0 category, while 39 cases (34.8%) were classified as HER2-low (Table 1). The gene discussed is ERBB2; the disease is maternal uniparental disomy of chromosome 20.